Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants

Cochrane Database of Systematic Reviews

Volumn 2020, Issue 2, 2020, Pages

  Aher, Sanjay M ^a   Ohlsson, Arne ^b  

^a Dr Aher's Neocare Hospital   (India)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; EPO PROTEIN, HUMAN; RECOMBINANT ERYTHROPOIETIN;

ADVERSE OUTCOME; ALL CAUSE MORTALITY; ANEMIA; BLOOD DONOR; BODY WEIGHT GAIN; BRAIN HEMORRHAGE; COMPARATIVE STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EARLY INTERVENTION; ERYTHROCYTE TRANSFUSION; EXPOSURE; HEMATOCRIT; HOSPITAL MORTALITY; HUMAN; LATE INTERVENTION; LENGTH OF STAY; LOW BIRTH WEIGHT; LUNG DYSPLASIA; MEDICAL PROCEDURES; MORTALITY RATE; NECROTIZING ENTEROCOLITIS; OXYGEN SUPPLY; PLATELET COUNT; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; REVIEW; RISK FACTOR; RISK REDUCTION; SUDDEN INFANT DEATH SYNDROME; SYSTEMATIC REVIEW; THROMBOCYTOSIS; TREATMENT OUTCOME; BLOOD; META ANALYSIS; NEWBORN; NEWBORN ANEMIA; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANEMIA, NEONATAL; EPOETIN ALFA; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETINOPATHY OF PREMATURITY;

EID: 85079334554     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004865.pub4     Document Type: Review

References (31)

1. Donato H, Vain N, Rendo P, Vivas N, Prudent L, Larguia M, et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial. Pediatrics 2000;105:1066-72. x-wiley/crsRef/2936510
2. Maier RF, Obladen M, Muller-Hansen I, Kattner E, Merz U, Arlettaz R, et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics 2002;141:8-15. x-wiley/crsRef/2936512
3. Rudzinska IM, Kornacka MK, Pawluch R. Treatment with human recombinant erythropoietin and frequency of retinopathy of prematurity [Leczenie preparatami ludzkiej rekombinowanej erytropoetyny a czeztosc retinopatii u noworodkow przedwczesnie urodzonych (Polish)]. Prezglad Lekarski 2002;59 Supplement 1:83-5. x-wiley/crsRef/2936514
4. Aher S, Ohlsson A. Late erythropoietin for preventing red blood cell transfusion. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD004868.pub2]
5. Brown MS, Phibbs RH, Garcia JF, Dallman PR. Postnatal changes in erythropoietin levels in untransfused premature infants. Journal of Pediatrics 1983;103:612-7.
6. Dallman PR. Anemia of prematurity. Annual Review of Medicine 1981;32:143-60.
7. Dame C, Juul SE, Christensen RD. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biology of the Neonate 2001;79:228-35.
8. Finch CA. Erythropoiesis, erythropoietin and iron. Blood 1982;60:1241-6.
9. Garcia MG, Hutson AD, Christensen RD. Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta-analysis. Journal of Perinatology 2002;22:108-11.
10. Genen LH, Klenoff H. Iron supplementation for erythropoietin-treated preterm infants. Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD003061.pub2]
11. Hesse L, Eberl W, Schlaud M, Poets CF. Blood transfusion. Iron load and retinopathy of prematurity. European Journal of Pediatrics 1997;156:465-70.
12. Higgin JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003;327:557-60.
13. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0. The Cochrane Collaboration, 2011.
14. Juul S. Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage. Acta Paediatrica Supplement 2002;91:36-42.
15. Kotto-Kome AC, Garcia MG, Calhoun DA, Christensen RD. Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on "early" and "late" erythrocyte transfusions: a meta-analysis. Journal of Perinatology 2004;24:24-9.
16. Ohls RK. The use of erythropoietin in neonates. Clinics in Perinatology 2000;27:681-96.
17. Ohls RK. Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out. Journal of Pediatrics 2002;141:3-6.
18. Ohls RK, Dai A. Long-acting erythropoietin: clinical studies and potential uses in neonates. Clinics in Perinatology 2004;31:77-89.
19. Ohlsson A, Aher SM. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD004863.pub2]
20. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
21. Shannon KM, Keith JF 3rd, Mentzer WC, Ehrenkranz RA, Brown MS, Widness JA, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight infants. Pediatrics 1995;95:1-8.
22. Stockman JA 3rd, Oski FA. Physiological anaemia of infancy and the anaemia of prematurity. Clinics in Hematology 1978;7:3-18.
23. Stockman JA 3rd. Anemia of prematurity. Current concept in the issue of when to transfuse. Pediatric Clinics of North America 1986;33:111-28.
24. Strauss RG. Current issues in neonatal transfusions. Vox Sanguinis 1986;51:1-9.
25. Vamvakas EC, Strauss RG. Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion 2001;41:406-15.
26. Warwood TL, Ohls RK, Wiedmeier SE, Lambert DK, Jones C, Scoffield SH, et al. Single-dose darbepoetin administration to anemic preterm neonates. Journal of Perinatology 2005;25:725-30.
27. Widness JA, Seward VJ, Kromer IJ, Burmeiser LF, Bell EF. Changing patterns of red blood cell transfusion in very low birth weight infants. Journal of Pediatrics 1996;129:680-7.
28. Yu Z, Guo X, Han S, Lu J, Sun Q, Ohlsson A. Erythropoietin for term and later preterm infants with hypoxicischemic encephalopathy (protocol). Cochrane Database of Systematic Reviews 2010, Issue 2. [DOI: 10.1002/14651858.CD008316]
29. Zipursky A. Erythropoietin therapy for premature infants: cost without benefit?. Pediatric Research 2000;48:136.
30. Aher SM, Ohlsson A. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD004865.pub2]
31. Aher SM, Ohlsson A. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD004865.pub2]